Quick Takeaways
- Point72 Asset Management, L.P. filed SCHEDULE 13G for Immunome Inc. Common Stock, par value $0.0001 per share (IMNM).
- Disclosed ownership: 5.9%.
- Date of event: 31 Jan 2025.
Point72 Asset Management, L.P. - 31 Jan 2025 SCHEDULE 13G Report for Immunome Inc. Common Stock, par value $0.0001 per share (IMNM)
- Filing Manager
- Point72 Asset Management, L.P.
- Reporting Manager
- Point72 Asset Management, L.P.
- Symbol
- IMNM
- Shares outstanding
- 82,832,373 shares
- Disclosed Ownership
- 4,887,110 shares
- Ownership
- 5.9%
- Form type
- SCHEDULE 13G
- Filing time
- 03 Feb 2025, 17:08:50 UTC
- Date of event
- 31 Jan 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"Point72 Asset Management, L.P. disclosed 5.9% ownership in Immunome Inc. Common Stock, par value $0.0001 per share (IMNM) on 31 Jan 2025."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 03 Feb 2025, 17:08.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (3)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Point72 Asset Management, L.P. | 5.9% | 4,887,110 | 0 | 4,887,110 | /s/ Jason M. Colombo | Jason M. Colombo, Authorized Person | |
| Point72 Capital Advisors, Inc. | 5.9% | 4,887,110 | 0 | 4,887,110 | /s/ Jason M. Colombo | Jason M. Colombo, Authorized Person | |
| Steven A. Cohen | 5.9% | 4,887,110 | 0 | 4,887,110 | /s/ Jason M. Colombo | Jason M. Colombo, Authorized Person |